Encompass Health Corp

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $247.6m $256.3m $292.3m $358.7m $284.2m $412.2m $271.0m $352.0m $455.7m $566.2m
Net Income (Loss) Available to Common Stockholders, Basic $247.6m $256.3m $375.4m $445.8m $368.8m $517.2m $269.8m $349.6m $452.9m $564.7m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $318.1m $335.4m $375.4m $445.8m $368.8m $517.2m $365.9m $463.0m $596.6m $759.1m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $247.6m $256.7m $291.2m $359.3m $284.2m $412.6m $257.1m $364.0m $458.5m $567.2m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $318.1m $335.8m $374.3m $446.4m $368.8m $517.6m $350.7m $475.0m $599.4m $760.1m
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $0 ($400k) $1.1m ($600k) $0 ($400k) $15.2m ($12.0m) ($2.8m) ($1.0m)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $0 ($400k) $1.1m ($600k) $0 ($400k) $13.9m ($12.0m) ($2.8m) ($1.0m)
Net Income (Loss) Attributable to Noncontrolling Interest $70.5m $79.1m $83.1m $87.1m $84.6m $105.0m $94.9m $111.0m $140.9m $192.9m
Depreciation, Depletion and Amortization $172.6m $183.8m $199.7m $218.7m $243.0m $256.6m $243.6m $273.9m $299.6m $327.9m
Depreciation $102.3m $111.8m $124.2m $130.0m $151.1m $166.2m $187.3m $215.7m $245.1m $273.9m
Amortization of Debt Issuance Costs and Discounts $13.8m $8.7m $4.0m $4.5m $7.2m $7.8m $9.7m $9.5m $9.7m $9.6m
Amortization of Intangible Assets $48.5m $49.3m $51.4m $58.4m $59.8m $56.4m $28.8m $32.5m $28.8m $28.3m
Deferred Income Tax Expense (Benefit) $132.9m $75.6m ($9.1m) $40.0m $52.4m $27.8m $27.9m $3.9m $10.7m $22.3m
Share-based Payment Arrangement, Noncash Expense $27.4m $47.7m $85.9m $114.4m $29.5m $32.8m $29.2m $50.6m $48.3m $56.5m
Payment, Tax Withholding, Share-based Payment Arrangement $11.6m $8.3m $16.6m $15.7m $16.4m $7.3m $8.2m $12.1m $20.0m
Share-based Payment Arrangement, Expense $48.3m $56.5m
Gain (Loss) on Sale of Assets and Asset Impairment Charges ($17.4m) ($2.7m)
Goodwill, Impairment Loss $0 $0 $0 $0 $0
Gain (Loss) on Extinguishment of Debt ($7.4m) ($10.7m) $0 ($7.7m) ($2.3m) ($1.0m) ($1.4m) $0 ($600k) $0
Income (Loss) from Equity Method Investments $9.8m $8.0m $8.7m $6.7m $3.5m $4.0m $2.9m $3.2m $3.0m $4.3m
Income Tax Expense (Benefit) $163.9m $160.6m $118.9m $115.9m $103.8m $139.6m $100.1m $132.2m $150.2m $192.9m
Interest Expense Nonoperating $137.4m $123.2m
Other Nonoperating Income (Expense) $2.9m $4.1m $2.2m $30.5m $10.6m $12.3m ($5.2m) $15.7m $20.1m $18.8m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $127.5m $83.9m ($7.0m) $22.9m $38.1m $64.3m $16.9m $22.4m ($3.0m) $15.2m
Increase (Decrease) in Accounts Payable $6.3m $7.5m $6.6m ($6.1m) $13.6m $14.9m $2.3m $11.8m $3.0m ($22.6m)
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $3.3m
Equity Securities, FV-NI, Gain (Loss) $1.0m $2.5m
Equity Securities, FV-NI, Unrealized Gain (Loss) $1.7m $1.2m $400k $600k ($7.4m) $1.3m $1.0m $2.1m
General and Administrative Expense $133.4m $171.7m $220.2m $247.0m $155.5m $197.3m $154.3m $201.7m $209.2m $236.2m
Goodwill $1.9b $2.0b $2.1b $2.3b $2.3b $2.4b $1.3b $1.3b $1.3b $1.3b
Proceeds from Contributions from Affiliates $20.8m $12.6m $15.9m $34.9m $57.2m $64.1m $68.3m $140.4m $1.8m
Accounts receivable ($127.5m) ($83.9m) $7.0m ($22.9m) ($38.1m) ($64.3m) ($16.9m) ($22.4m) $3.0m ($15.2m)
Accounts payable $6.3m $7.5m $6.6m ($6.1m) $13.6m $14.9m $2.3m $11.8m $3.0m ($22.6m)
Net Cash Provided by (Used in) Operating Activities $634.4m $657.2m $762.4m $635.3m $704.7m $715.8m $705.8m $850.8m $1.0b $1.2b
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $177.7m $225.8m $254.5m $372.4m $396.0m $528.9m $564.8m ($583.1m) ($642.5m) ($736.4m)
Payments to Acquire Businesses, Net of Cash Acquired $48.1m $38.8m $143.9m $231.5m $1.1m $118.6m $0
Payments for (Proceeds from) Other Investing Activities $1.6m $3.0m $8.8m $6.5m $2.1m ($12.5m) $4.2m ($3.3m) $7.2m $16.6m
Net Cash Provided by (Used in) Investing Activities ($245.0m) ($284.5m) ($424.5m) ($657.4m) ($407.5m) ($666.3m) ($627.0m) ($602.8m) ($653.3m) ($764.6m)
Cash flows from financing activities:
Repayments of Long-term Debt $202.1m $129.9m $20.6m $519.5m
Payments for Repurchase of Common Stock $65.6m $38.1m $0 $45.9m $6.1m $0 $0 $31.1m $158.0m
Payments of Ordinary Dividends, Common Stock $83.8m $91.5m $100.8m $108.7m $111.9m $112.4m $99.0m $60.4m $62.8m $71.1m
Proceeds from (Payments for) Other Financing Activities $8.8m $400k $6.1m ($8.3m) $1.0m $700k $300k $1.2m $2.1m ($2.8m)
Net Cash Provided by (Used in) Financing Activities ($410.5m) ($358.8m) ($321.2m) $48.2m ($145.9m) ($240.1m) ($145.7m) ($197.2m) ($330.6m) ($431.2m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $16.7m $26.1m $151.3m ($190.6m) ($66.9m) $50.8m $18.9m ($20.2m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $133.5m $159.6m $310.9m $120.3m $53.4m $104.2m $123.1m $102.9m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities ($64.9m) ($51.9m) ($75.4m) $155.7m $168.4m $168.4m $178.4m $147.7m $146.8m $133.1m
Income Taxes Paid, Net ($11.6m) ($19.8m) ($8.3m) ($16.6m) ($15.7m) ($16.4m) ($7.3m) ($8.2m) ($12.1m) $124.0m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.